These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8882901)

  • 1. Structure and in vivo activity of hypoglycaemic analogues of human growth hormone (6-13).
    Thompson P; Lim N; Ede NJ; Ng FM; Rae ID; Hearn MT
    Drug Des Discov; 1995 Aug; 13(1):55-72. PubMed ID: 8882901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and conformation of constrained peptides with hypoglycaemic activity derived from human growth hormone.
    Ede NJ; Rae ID; Hearn MT
    Int J Pept Protein Res; 1994 Dec; 44(6):568-81. PubMed ID: 7705979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of constrained peptide analogues related to the N-terminal region of human growth hormone.
    Ede NJ; Lim N; Rae ID; Ng FM; Hearn MT
    Pept Res; 1991; 4(3):171-6. PubMed ID: 1823187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microwave-assisted solid phase synthesis, PEGylation, and biological activity studies of glucagon-like peptide-1(7-36) amide.
    Chi Y; Zhang H; Huang W; Zhou J; Zhou Y; Qian H; Ni S
    Bioorg Med Chem; 2008 Aug; 16(16):7607-14. PubMed ID: 18656368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monomeric B27 Lys destripeptide insulin: semisynthesis, characterization and biological activity.
    Ding JG; Cui DF; Zhang YS
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):215-8. PubMed ID: 12621544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues.
    Tran TA; Mattern RH; Afargan M; Amitay O; Ziv O; Morgan BA; Taylor JE; Hoyer D; Goodman M
    J Med Chem; 1998 Jul; 41(15):2679-85. PubMed ID: 9667958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing alpha-amino-iso-butyric acid (Aib) residues.
    Peggion E; Mammi S; Schievano E; Schiebler L; Corich M; Rosenblatt M; Chorev M
    Biopolymers; 2003 Mar; 68(3):437-57. PubMed ID: 12601801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers.
    Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ
    Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies.
    Cervini LA; Donaldson CJ; Koerber SC; Vale WW; Rivier JE
    J Med Chem; 1998 Feb; 41(5):717-27. PubMed ID: 9513600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase synthesis of cyclic analogues related to the hypoglycaemic peptide hGH(6-13): comparison of two i-->i + 4 lactam cyclization procedures.
    Cavallaro V; Thompson PE; Hearn MT
    J Pept Sci; 2001 Oct; 7(10):529-36. PubMed ID: 11695648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vivo antidiabetic activity of novel dispiropyrrolidines through [3+2] cycloaddition reactions with thiazolidinedione and rhodanine derivatives.
    Murugan R; Anbazhagan S; Lingeshwaran ; Sriman Narayanan S
    Eur J Med Chem; 2009 Aug; 44(8):3272-9. PubMed ID: 19395129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity studies on the corticotropin releasing factor antagonist astressin, leading to a minimal sequence necessary for antagonistic activity.
    Rijkers DT; Kruijtzer JA; van Oostenbrugge M; Ronken E; den Hartog JA; Liskamp RM
    Chembiochem; 2004 Mar; 5(3):340-8. PubMed ID: 14997526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemic action of a novel constrained analog of human growth hormone-(6-13).
    Lim N; Ng FM; Wu ZM; Ede N; Hearn MT
    Endocrinology; 1992 Aug; 131(2):835-40. PubMed ID: 1639027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L; Barth T; Jirácek J; Barthová J; Zórad S
    Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of Nb2 mitogenesis by an analogue of human growth hormone (110-127).
    Kornberg LJ; Liberti JP
    Biochem Int; 1992 Dec; 28(5):873-9. PubMed ID: 1288497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
    Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
    J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering novel VPAC2-selective agonists with improved stability and glucose-lowering activity in vivo.
    Pan CQ; Li F; Tom I; Wang W; Dumas M; Froland W; Yung SL; Li Y; Roczniak S; Claus TH; Wang YJ; Whelan JP
    J Pharmacol Exp Ther; 2007 Feb; 320(2):900-6. PubMed ID: 17110523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR structure of two novel polyethylene glycol conjugates of the human growth hormone-releasing factor, hGRF(1-29)-NH2.
    Digilio G; Barbero L; Bracco C; Corpillo D; Esposito P; Piquet G; Traversa S; Aime S
    J Am Chem Soc; 2003 Mar; 125(12):3458-70. PubMed ID: 12643708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyses of insulin-potentiating fragments of human growth hormone by computative simulation; essential unit for insulin-involved biological responses.
    Ohkura K; Hori H
    Bioorg Med Chem; 2000 Jul; 8(7):1733-40. PubMed ID: 10976521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.